Abstract
The tumor suppressor gene p53 spearheads clinical studies that apply gene transfer technology for cancer treatment. p53 has an effective therapeutic potential, nevertheless its efficacy isn't high in every type of tumor. The presence of p53 mutants in tumors may affect the treatment with exogenous wild type p53. New drugs (like the p53-vectors) must be tested and analyzed against many dif…